'Living Drug' That Fights Cancer By Harnessing The Immune System Clears Key Hurdle
An advisory panel to the Food and Drug Administration recommends the agency, for the first time, approve a new kind of treatment that uses genetically modified immune cells to attack cancer cells.
Read more on NPR
Children's Health
July 13, 2017 at 05:08AM
Thứ Năm, 13 tháng 7, 2017
Đăng ký:
Đăng Nhận xét (Atom)
0 nhận xét:
Đăng nhận xét